NDC 62856-455

DAYVIGO

Lemborexant

DAYVIGO is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Eisai Inc.. The primary component is Lemborexant.

• Product ID: 62856-455_08ce5d4f-11e3-42c9-9e5a-801a3afca000
• NDC: 62856-455
• Product Type: Human Prescription Drug
• Proprietary Name: DAYVIGO
• Generic Name: Lemborexant
• Dosage Form: Tablet, Film Coated
• Route of Administration: ORAL
• Marketing Start Date: 2020-04-07
• Marketing Category: NDA / NDA
• Application Number: NDA212028
• Labeler Name: Eisai Inc.
• Substance Name: LEMBOREXANT
• Active Ingredient Strength: 5 mg/1
• DEA Schedule: CIV
• NDC Exclude Flag: N
• Listing Certified Through: 2021-12-31

Packaging

NDC 62856-455-10

5 CARTON in 1 TRAY (62856-455-10) > 1 BLISTER PACK in 1 CARTON > 10 TABLET, FILM COATED in 1 BLISTER PACK

• Marketing Start Date: 2020-04-07
• NDC Exclude Flag: N
• Sample Package?: Y

NDC SPL Data Element Entries

NDC 62856-455-10 [62856045510]

DAYVIGO TABLET, FILM COATED

• Marketing Category: NDA
• Application Number: NDA212028
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2020-04-07

Drug Details

Active Ingredients

Ingredient	Strength
LEMBOREXANT	5 mg/1

NDC Crossover Matching brand name "DAYVIGO" or generic name "Lemborexant"

NDC	Brand Name	Generic Name
62856-405	DAYVIGO	lemborexant
62856-410	DAYVIGO	lemborexant
62856-455	DAYVIGO	lemborexant